AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Kakolyris, S Giatromanolaki, A Koukourakis, M Powis, G Souglakos, J Sivridis, E Georgoulias, V Gatter, KC Harris, AL
Citation: S. Kakolyris et al., Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer, CLIN CANC R, 7(10), 2001, pp. 3087-3091

Authors: Papakostas, P Kouroussis, C Androulakis, N Samelis, G Aravantinos, G Kalbakis, K Sarra, E Souglakos, J Kakolyris, S Georgoulias, V
Citation: P. Papakostas et al., First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study, EUR J CANC, 37(15), 2001, pp. 1833-1838

Authors: Kakolyris, S Mavroudis, D Tsavaris, N Souglakos, J Tsiafaki, P Kalbakis, K Agelaki, S Androulakis, N Georgoulias, V
Citation: S. Kakolyris et al., Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study, ANN ONCOL, 12(2), 2001, pp. 193-197

Authors: Kouroussis, C Kakolyris, S Mavroudis, D Androulakis, N Kalbakis, K Agelaki, S Sarra, E Souglakos, J Christodoulakis, M Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors, AM J CL ONC, 24(4), 2001, pp. 404-407

Authors: Samonis, G Anatoliotaki, M Apostolakou, H Souglakos, J Georgoulias, V
Citation: G. Samonis et al., Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease, SC J IN DIS, 33(7), 2001, pp. 553-555

Authors: Kakolyris, S Kouroussis, C Souglakos, J Mavroudis, D Agelaki, S Kalbakis, K Androulakis, N Vardakis, N Vamvakas, L Georgoulias, V
Citation: S. Kakolyris et al., A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors, ONCOL-BASEL, 61(4), 2001, pp. 265-270

Authors: Kouroussis, C Souglakos, J Kakolyris, S Mavroudis, D Malamos, N Kalbakis, K Androulakis, N Agelaki, A Vardakis, N Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study, ONCOL-BASEL, 61(1), 2001, pp. 36-41

Authors: Kakolyris, S Souglakos, J Kouroussis, C Androulakis, N Mavroudis, D Kalbakis, K Kotsakis, A Vardakis, N Koukourakis, M Romanos, J Georgoulias, V
Citation: S. Kakolyris et al., A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer, ONCOL-BASEL, 60(3), 2001, pp. 207-213

Authors: Kalbakis, K Kouroussis, C Kakolyris, S Mavroudis, D Souglakos, J Agelaki, S Vamvakas, L Christodoulakis, M Stylianou, K Georgoulias, V
Citation: K. Kalbakis et al., Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuousinfusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes, BR J CANC, 85(6), 2001, pp. 798-802

Authors: Kakolyris, S Kouroussis, C Kalbakis, K Mavroudis, D Souglakos, J Vardakis, N Kremos, S Georgoulias, V
Citation: S. Kakolyris et al., Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin, ANN ONCOL, 11(6), 2000, pp. 757-760

Authors: Kouroussis, C Agelaki, S Mavroudis, D Souglakos, J Kakolyris, S Kalbakis, K Vardakis, N Reppa, D Hatzidaki, D Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., A dose escalation study of weekly docetaxel in patients with advanced solid tumors, CANC CHEMOT, 46(6), 2000, pp. 488-492

Authors: Mavroudis, D Kourousis, C Androulakis, N Kalbakis, K Agelaki, S Kakolyris, S Souglakos, J Sarra, E Vardakis, N Hatzidaki, D Sarmonis, G Georgoulias, V
Citation: D. Mavroudis et al., Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial, AM J CL ONC, 23(4), 2000, pp. 341-344

Authors: Kouroussis, C Samonis, G Androulakis, N Souglakos, J Voloudaki, A Dimopoulos, MA Kotsakis, T Kakolyris, S Kalbakis, K Georgoulias, V
Citation: C. Kouroussis et al., Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy - A report of five cases, AM J CL ONC, 23(3), 2000, pp. 309-313

Authors: Kakolyris, S Souglakos, J Agelaki, S Kourousis, C Mavroudis, D Sarra, E Malliotakis, P Georgoulias, V
Citation: S. Kakolyris et al., A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy, LUNG CANC, 30(3), 2000, pp. 193-198

Authors: Mavroudis, D Kourousis, C Kakolyris, S Agelaki, S Kalbakis, K Androulakis, N Souglakos, J Vardakis, N Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report, SEMIN ONCOL, 27(1), 2000, pp. 25-30

Authors: Kotsakis, A Sarra, E Peraki, M Koukourakis, M Apostolaki, S Souglakos, J Mavromanomakis, E Vlachonikolis, J Georgoulias, V
Citation: A. Kotsakis et al., Docetaxel-induced lymphopenia in patients with solid tumors - A prospective phenotypic analysis, CANCER, 89(6), 2000, pp. 1380-1386

Authors: Kouroussis, C Androulakis, N Kakolyris, S Souglakos, J Kotsakis, T Mavroudis, D Katsogridakis, K Vardakis, N Hatzidaki, D Samonis, G Vlachonikolis, J Georgoulias, V
Citation: C. Kouroussis et al., Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer, J CL ONCOL, 17(3), 1999, pp. 862-869

Authors: Kouroussis, C Georgoulias, V Souglakos, J Simvoulakis, E Karabekios, S Samonis, G
Citation: C. Kouroussis et al., Spontaneous spondylodiscitis caused by Klebsiella pneumoniae, INFECTION, 27(6), 1999, pp. 368-369

Authors: Manousos, O Souglakos, J Bosetti, C Tzonou, A Chatzidakis, V Trichopoulos, D Adami, HO Mantzoros, C
Citation: O. Manousos et al., IGF-I and IGF-II in relation to colorectal cancer, INT J CANC, 83(1), 1999, pp. 15-17
Risultati: 1-19 |